Evaluation of a bioceramic-based nanocomposite material for controlled delivery of a non-steroidal anti-inflammatory drug

Medical Engineering and Physics

Volumn 31, Issue 10, 2009, Pages 1205-1213

  Hesaraki, S ^a   Moztarzadeh, F ^b   Nezafati, N ^b  

^a MATERIALS AND ENERGY RESEARCH CENTER   (Iran)

^b AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

Apatite; Bone repair; Calcium sulfate; Indomethacin; Nanocomposite

Indexed keywords

BASIC PROPERTIES; BONE DEFECT; BONE REPAIR; CALCIUM SULFATE; CONTROLLED DELIVERY; CONTROLLED RELEASE; CULTURE PLATES; CYTOTOXIC EFFECTS; IN-VITRO; INDOMETHACIN; INITIAL SETTING TIME; INJECTABILITY; MOUSE-FIBROBLASTS; NANOCOMPOSITE MATERIALS; NANOCRYSTALLINE APATITES; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; SETTING TIME; SPHERICAL MORPHOLOGIES; SUSTAINED RELEASE;

APATITE; BIOCOMPATIBILITY; BONE; CALCIUM; CALCIUM ALLOYS; CELL CULTURE; CEMENTS; COMPRESSIVE STRENGTH; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; NANOCOMPOSITES; PHOSPHATE MINERALS; SANDWICH STRUCTURES; SETTING;

BONE CEMENT;

APATITE; BIOCERAMICS; BONE CEMENT; CALCIUM SULFATE; INDOMETACIN; NANOCOMPOSITE;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BONE DEFECT; CELL STRAIN L 929; CELL STRUCTURE; COMPRESSIVE STRENGTH; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FIBROBLAST; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APATITES; BIOCOMPATIBLE MATERIALS; CALCIUM SULFATE; CELL PROLIFERATION; CERAMICS; COMPRESSIVE STRENGTH; CRYSTALLIZATION; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FRACTURE HEALING; INDOMETHACIN; MICE; MICROSCOPY, ELECTRON, SCANNING; SOLUBILITY;

EID: 70449524426     PISSN: 13504533     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medengphy.2009.07.019     Document Type: Article

References (39)

1. Ragel C.V., and Vallet-Regí M. In vitro bioactivity and gentamicin release from glass-polymer-antibiotic composites. J Biomed Mater Res 51 (2000) 424-429
2. Arcos D., Ragel C.V., and Vallet-Regí M. Bioactivity in glass/PMMA composites used as drug delivery system. Biomaterials 22 (2001) 701-708
3. Zhang J.X., Li X.J., Qiu L.Y., Li X.H., Yan M.Q., Yi Jin, et al. Indomethacin-loaded polymeric nanocarriers based on amphiphilic polyphosphazenes with poly (N-isopropylacrylamide) and ethyl tryptophan as side groups: preparation, in vitro and in vivo evaluation. J Control Release 116 (2006) 322-329
4. Cai X., Yang L., Zhang L.M., and Wu Q. Synthesis and anaerobic biodegradation of indomethacin-conjugated cellulose ethers used for colon-specific drug delivery. Bioresour Technol 100 (2009) 4164-4170
5. Corry D., and Moran J. Assessment of acrylic bone cement as a local delivery vehicle for the application of non-steroidal anti-inflammatory drugs. Biomaterials 19 (1998) 1295-1301
6. Hesaraki S., Nemati R., and Nosoudi N. Preparation and characterization of porous calcium phosphate bone cement as antibiotic carrier. Adv Appl Ceram 108 (2009) 231-240
7. Santin M., Motta A., Borzachiello A., Nicolais L., and Ambrosio L. Effect of PMMA cement radical polymerisation on the inflammatory response. J Mater Sci Mater Med 15 (2004) 1175-1180
8. Otsuka M., Nakahigashi Y., Matsuda Y., Fox J.L., Higuchi W.I., and Sugiyama Y. Effect of geometrical cement size on in vitro and in vivo indomethacin release from self-setting apatite cement. J Control Release 52 (1998) 281-289
9. Yuasa T., Miyamoto Y., Ishikawa K., Takechi M., Nagayama M., and Suzuki K. In vitro resorption of three apatite cements with osteoclasts. J Biomed Mater Res 54 (2001) 344-350
10. Costantino P.D., Friedman C.D., Jones K., Chow L.C., and Sisson G.A. Experimental hydroxyapatite cement cranioplasty. Plast Reconstr Surg 90 (1992) 174-191
11. Krisanapiboon A., Buranapanitkit B., and Oungbho K. Biocompatability of hydroxyapatite composite as a local drug delivery system. J Orthop Surg (Hong Kong) 14 (2006) 315-318
12. Besson W.H. Plaster of Paris as an alloplastic implant in the frontal sinus. Arch Otolaryngol Head Neck Surg 107 (1981) 664-669
13. Lee G.H., Khoury J.G., Bell J.E., and Buckwalter J.A. Adverse reactions to OsteoSet bone graft substitute, the incidence in a consecutive series. Iowa Orthop J 22 (2002) 35-38
14. Robinson D., Alk D., Sandbank J., Farber R., and Halperin N. Inflammatory reactions associated with a calcium sulfate bone substitute. Ann Transplant 4 (1999) 91-97
15. Rauschmann M.A., Wichelhaus T.A., Stirnal V., Dingeldein E., Zichner L., Schnettler R., et al. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 26 (2005) 2677-2684
16. Doadrio J.C., Arcos D., Cabanas M.V., and Vallet-Regi M. Calcium sulphate-based cements containing cephalexin. Biomaterials 25 (2004) 2629-2635
17. Englert C., Angele P., Fierlbeck J., Dendorfer S., Schubert T., Müller R., et al. Conductive bone substitute material with variable antibiotic delivery. Unfallchirurg 110 (2007) 408-413
18. Rey C., Combes C., Drouet C., Sfihi H., and Barroug A. Physico-chemical properties of nanocrystalline apatites: implications for biominerals and biomaterials. Mater Sci Eng C 27 (2007) 198-205
19. Dorozhkina E.I., and Dorozhkin S.V. Structure and properties of the precipitates formed from condensed solutions of the revised simulated body fluid. J Biomed Mater Res A 67 (2003) 578-581
20. Hesaraki S., Zamanian A., and Moztarzadeh F. Effect of adding sodium hexametaphosphate liquefier on basic properties of calcium phosphate cements. J Biomed Mater Res A 88 (2009) 314-321
21. Kokubo T., Kushitani H., Sakka S., Kitsugi T., and Yamamuro T.J. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J Biomed Mater Res 24 (1990) 721-734
22. Fini G., Fazio G., and Feroci G. Solubility and solubilization properties of NSAIDs. Int J Pharm 126 (1995) 95-102
23. Tamimi F., Torres J., Bettini R., Ruggera F., Rueda C., López-Ponce M., et al. Doxycycline sustained release from brushite cements for the treatment of periodontal diseases. J Biomed Mater Res A 85 (2008) 707-714
24. Gbureck U., Vorndran E., Müller F.A., and Barralet J.E. Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices. J Control Release 122 (2007) 173-180
25. Hesaraki S., and Nemati R. Cephalexin-loaded injectable macroporous calcium phosphate bone cement. J Biomed Mater Res B (Appl Biomater) 89 (2009) 342-352
26. Mao C., Li H., Cui F., Ma C., and Feng Q. Oriented growth of phosphates on polycrystalline titanium in a process mimicking biomineralization. J Cryst Growth 206 (1999) 308-321
27. Gitelis S., Piasecki P., Turner T., Haggard W., Charters J., and Urban R. Preliminary report: use of a calcium sulfate-based bone graft-substitute for benign bone lesions. Orthopedics 24 (2001) 162-166
28. Kelly C.M., Wilkins R.M., Gitelis S., Hartjen C., Watson J.T., and Kim P.T. The use of a surgical grade calcium sulfate as a bone graft substitute. Clin Orthop 382 (2001) 44-50
29. Lokaler S.A. Antibiotikumtrager aus Kalziumsulfat: Verträ glichkeit im Gewebe und Pharmakokinetik der angewendeten Antibiotika nach Implantation in Kaninchen. Biomaterialien in der Medizin (1999), Kohler, Giessen p. 105-8
30. Hesaraki S., Moztarzadeh F., and Solati-Hashjin M. Phase evaluation of an effervescent-added apatitic calcium phosphate bone cement. J Biomed Mater Res B (Appl Biomater) 79 (2006) 203-209
31. Du C., Klasens P., Haan R.E., Bezemer J., Cui F.Z., de Groot K., et al. Biomimetic calcium phosphate coatings on Polyactive 1000/70/30. J Biomed Mater Res 59 (2002) 535-546
32. Landi E., Tampieri A., Celotti G., Langenati R., Sandri M., and Sprio S. Nucleation of biomimetic apatite in synthetic body fluids: dense and porous scaffold development. Biomaterials 26 (2005) 2835-2845
33. O'Brien M., McCauley J., and Cohen E. Analytical profiles of drug substances. Indomethacin 13 (1984) p.21-234
34. Hesaraki S., Moztarzadeh F., and Solati-Hashjin M. Phase evaluation of an effervescent-added apatitic calcium phosphate bone cement. J Biomed Mater Res B (Appl Biomater) 79B (2006) 203-209
35. Lacout JL, Freche M, Goncalves S, Rodriguez F. Method for preparing a calcium phosphate pasty material for injection; 2005, US Pat 6,923,989.
36. Heini P.F., Berlemann U., Kaufmann M., Lippuner K., Fankhauser C., and van Landuyt P. Augmentation of mechanical properties in osteoporotic vertebral bones-a biomechanical investigation of vertebroplasty efficacy with different bone cements. Eur Spine J 10 (2001) 164-171
37. Bohner M., and Baroud G. Injectability of calcium phosphate pastes. Biomaterials 26 (2005) 1553-1563
38. Otsuka M., Matsuda Y., Wang Z., Fox J.L., and Higuchi W.I. Effect of sodium bicarbonate amount on in vitro indomethacin release from self-setting carbonated-apatite cement. Pharm Res 14 (1997) 444-449
39. Kosmidis K., Rinaki E., Argyrakis P., and Macheras P. Analysis of Case II drug transport with radial and axial release from cylinders. Int J Pharm 254 (2003) 183-188